Effects of GLP-1 Receptor Agonists on Microglia in Animal Studies
GLP-1 receptor agonists were found to shift microglia towards an anti-inflammatory state, reducing neuroinflammation and increasing neuronal protection in preclinical models of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and multiple sclerosis.
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
These findings suggest that GLP-1 receptor agonists may be a promising avenue for treating neuroinflammatory conditions, potentially improving cognitive function and pain sensitivity.
What this does not prove
This is a review article summarizing existing evidence, not presenting new experimental data, so it cannot establish causation or human efficacy.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Neuroinflammation
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceModulating Microglial Activation Through GLP-1 Pathways: A New Frontier in Neuroinflammation Research. ↗DOI: 10.1111/ejn.70718
Supporting passages (6)
research categoriesTitle: Modulating Microglial Activation Through GLP-1 Pathways: A New Frontier in Neuroinflammation Research.
interventionRecent investigations have identified GLP-1 receptor agonists (GLP-1 RAs) as potent pharmacological agents that can regulate the activity of the microglia.
findingsGLP-1RA attaches to the GLP-1 receptor found on the microglia to cause a phenotypic shift to the anti-inflammatory M2 form, which, in turn, reduces neuroinflammation and increases neuronal protection.
limitationsTitle: Modulating Microglial Activation Through GLP-1 Pathways: A New Frontier in Neuroinflammation Research.
peer reviewedPublication types: Journal Article; Review
subjectsMeSH terms: Microglia; Animals; Humans; Neuroinflammatory Diseases; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor Agonists; Neurodegenerative Diseases; Glucagon-Like Peptide-1 Receptor; Signal Transduction
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.